Imagine the Next Green Revolution
A conceptual diagram illustrating the securing of hemp cultivation and extraction technologies
Cannabinoid, the main ingredient of hemp,
INGR, selected as a special zone operator for the Gyeongbuk Industrial Hemp Regulation and began an empirical study on the cultivation of CBD-rich industrial Hemp.
Cannabis sativa, also known as hemp, is classified as a narcotic marijuana (0.3% or more) and a low-drug industrial hemp (less than 0.3%) depending on the content of tetrahydrocannabinol (THC). Edible sites are seeds, roots, and stems, and leaves, flowers, and seed shells contain high levels of THC, a hallucinogenic ingredient that acts on cannabinoid receptors
In some countries, including the United States, Canada, and the Netherlands, cannabis industrialization has been activated, centering on medical cannabis, by legalizing cannabis cultivation under certain conditions and restrictions.
In Korea, it is cultivated in Andong, Gyeongsangbuk-do, and Dangjin, Chungcheongnam-do for the purpose of producing textiles, and the sale of hemp oil using hemp seeds is allowed. Since March 2019, the use of cannabis-based drugs has been approved for the treatment of rare and intractable diseases without alternative treatments in Korea.
Cannabinoid, a major component of cannabis, has high potential in the food and pharmaceutical market, with its efficacy in relieving pain, reducing inflammation, suppressing vomiting and nausea, protecting nerves, anti-diabetes, anti-ischemia, antimicrobial, sleep aids, and bone growth.
